Valeant Pharmaceuticals International, Inc. (VRX) saw a big move last session, as the company’s shares fell by about 5% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for VRX, as the stock is now down 12.1% since July 30.
This slump shouldn’t be too much of a surprise to investors, as this pharmaceutical company has seen 1 negative revision in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
VRX currently has a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Med-Drugs industry include Endo International plc (ENDP), Endocyte, Inc. (ECYT), and Salix Pharmaceuticals Ltd. (SLXP). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
VALEANT PHARMACEUTICALS INTERNAT (VRX): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
ENDOCYTE INC (ECYT): Free Stock Analysis Report
SALIX PHARMACEUTICALS LTD (SLXP): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading